Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.
about
Interaction between ROCK II and nucleophosmin/B23 in the regulation of centrosome duplicationTumor necrosis factor disrupts claudin-5 endothelial tight junction barriers in two distinct NF-κB-dependent phasesDistinct roles for ROCK1 and ROCK2 in the regulation of keratinocyte differentiationThe MEK1 scaffolding protein MP1 regulates cell spreading by integrating PAK1 and Rho signals.Subversion of the actin cytoskeleton during viral infectionCell culture-based analysis of postsynaptic membrane assembly in muscle cellsBerberine inhibits metastasis of nasopharyngeal carcinoma 5-8F cells by targeting Rho kinase-mediated Ezrin phosphorylation at threonine 567RhoA/ROCK regulation of neuritogenesis via profilin IIa-mediated control of actin stabilityPharmacological reversal of endothelin-1 mediated constriction of the spiral modiolar artery: a potential new treatment for sudden sensorineural hearing loss.Novel Insights into the Roles of Rho Kinase in CancerThe Function of Rho-Associated Kinases ROCK1 and ROCK2 in the Pathogenesis of Cardiovascular DiseaseStructure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11Rat embryonic stem cells create new era in development of genetically manipulated rat modelsThe Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosisRole of Rho kinase signal pathway in inflammatory bowel diseaseRegulation of valve endothelial cell vasculogenic network architectures with ROCK and Rac inhibitors.Differential regulation of adhesion complex turnover by ROCK1 and ROCK2A Point Mutation in p190A RhoGAP Affects Ciliogenesis and Leads to Glomerulocystic Kidney DefectsROCK1 and 2 differentially regulate actomyosin organization to drive cell and synaptic polarity.Stretching morphogenesis of the roof plate and formation of the central canalThe RhoGEF TEM4 Regulates Endothelial Cell Migration by Suppressing Actomyosin ContractilityPericytes regulate vascular basement membrane remodeling and govern neutrophil extravasation during inflammationCortical instability drives periodic supracellular actin pattern formation in epithelial tubes.On-Chip Quantitative Measurement of Mechanical Stresses During Cell Migration with Emulsion Droplets.Cell cycle-dependent Rho GTPase activity dynamically regulates cancer cell motility and invasion in vivoPyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2)R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and MetastasisRho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary arteryEzrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motilityY-27632, an inhibitor of Rho-kinase, antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosumDLC1: a significant GAP in the cancer genomeWdr1-mediated cell shape dynamics and cortical tension are essential for epidermal planar cell polarity.The effect of substrate elasticity and actomyosin contractility on different forms of endocytosisFibronectin matrix assembly requires distinct contributions from Rho kinases I and -IIDisruption of K(2P)6.1 produces vascular dysfunction and hypertension in miceMotorized RhoGAP myosin IXb (Myo9b) controls cell shape and motility.A computational tool for quantitative analysis of vascular networksHuman keratinocytes are efficiently immortalized by a Rho kinase inhibitorMacrophage motility is driven by frontal-towing with a force magnitude dependent on substrate stiffnessSurvival of human embryonic stem cells implanted in the guinea pig auditory epithelium.
P2860
Q24305428-E0BB5FD5-E4ED-40E4-8733-5BB9590E8F99Q24324864-16BE3C47-46F7-49A2-A967-07C7F87A9E3DQ24337057-168F5E62-61AB-4DCB-BF87-1A50F71EB61BQ24529071-02B26C3F-6EC3-404F-BC2A-38BD1BB4B4A6Q24633026-CE974E14-912E-4D27-AFE7-69C1F63DABD4Q24641876-8838DCFC-CDBA-460F-9782-E24D1BB0F668Q24648113-2D78EFE6-9AA7-4437-93B1-B2BA6307329DQ24671491-E8536B0C-718C-4CEA-B666-3870BE81721DQ24812464-A52AFE4C-88C1-4D17-912F-321E04099F45Q26771368-4071BFDA-A659-4126-9908-BC2360146F75Q26774795-C0C720D3-55BE-4E23-99B3-E076505E7C25Q26776134-3F7D0ED5-6759-4A9D-A307-EA9B2784610CQ26795535-DFB689A9-2DFE-4CE4-A119-FCEB7644EC64Q27005980-751F3782-175B-4BB8-A269-EFC4212998FFQ27006502-B3F2B9B3-8591-450A-8D50-3468B630BA66Q27308671-10CF3243-9B03-4661-94F5-B504D30211E7Q27309003-1C19DC5D-DC65-4B86-A05B-59EA4E96E571Q27309265-364340F9-B660-4B94-9FA8-60DEFA8FC3FCQ27309510-06E8EE19-D0D7-4369-B457-84B31E2BDB0DQ27314877-DE2BFD89-2757-4503-BE02-9EDD3000EE2AQ27314891-D4DBF9A3-B97C-4464-A754-32BED7E419D3Q27318097-5783D365-B1E0-4F7F-8A0A-02896CBF5787Q27323450-62EE6EBE-373F-478A-B69E-B43EA27921A5Q27333574-2F549BBA-EA1C-486F-A0DC-D95BFF525A0AQ27339470-F06E0760-4621-4A37-859C-4F1E890B5E5FQ27675669-2D6AE03C-0FC6-4DBE-AFC8-7C6A45BD504BQ28265491-4F0A089E-01C7-4CF6-B460-8E9A56B5F11CQ28345899-40EBFAF8-E08F-48B4-B4A7-C2A1FE1C5E8AQ28366134-BB3D5EAE-9AB4-4B9D-9621-05245BCC58A6Q28366547-9FFF76BD-B0BB-4FEC-A41C-91B0E8B68D01Q28390592-20F1D1FF-21E9-43B2-B13C-69781376B4E7Q28507808-03370B73-0315-4C95-8269-BBB46C4A7EE9Q28538366-FA9F8AB2-8DF5-417C-B89A-1647C74B40D3Q28565264-AE8F918E-B626-4C67-ACE1-49EEA1C7538FQ28589505-B167F08F-E818-4A77-B7F0-AE4E9B69142AQ28592732-014ACABC-5D6F-443C-B510-3A9B722D5292Q28742663-6B058E84-3114-407B-A992-DE5FBCFCC514Q28750471-86065633-6B62-444D-9D1F-DAEA6FF541D2Q28821772-33008D0E-F956-4781-B09A-13BBDDCB8131Q30358943-41936D47-EF41-40E4-851E-44530030D5A7
P2860
Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.
@en
Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.
@nl
type
label
Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.
@en
Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.
@nl
prefLabel
Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.
@en
Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.
@nl
P2093
P1476
Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.
@en
P2093
Ishizaki T
Narumiya S
Nonomura K
Tamechika I
P304
P577
2000-05-01T00:00:00Z